Pure Global
NCT06328309

Impact of v Release on Dysphagia in Patients With Traumatic Brain Injury

Impact of Myofascial Release on Dysphagia in Patients With Traumatic Brain Injury: A Randomized Controlled Study
Copka Sonpashan·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Traumatic Brain Injury
Drug/Device/Intervention
Rehabilitation treatment
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Copka Sonpashan
Funder
Chao Phya Abhaibhubejhr Hospital
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2024
End date
Dec 01, 2024
Enrollment
80 participants
Primary outcome

Penetration-Aspiration Scale

Summary

The goal of this clinical trial is to explore Clinical Effect of Myofascial Release Therapy
 in Dysphagic Traumatic Brain injured Survivors. The main question it aims to answer is:
 
 • Can Myofascial Release Therapy improve swallowing function in Traumatic Brain injured
 Survivors? Patients will be randomly allocated into the control group or the experimental
 group, all under rehabilitation treatment, the experimental group will be given Myofascial
 Release Therapy. The study lasts 21 days for each patient. Researchers will compare the
 Functional Oral Intake Scale, Penetration-Aspiration Scale, Swallowing Quality of Life to see
 if the Myofascial Release Therapy can help improve the situation.

ICD-10 classifications
Diffuse brain injuryIntracranial injuryFocal brain injuryIntracranial injury, unspecifiedOther intracranial injuries
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06328309
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06328309 through Pure Global AI's free database. This phase not specified trial is sponsored by Copka Sonpashan and is currently Not yet recruiting. The study focuses on Traumatic Brain Injury. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.